Belgian health technology assessment (HTA) body to lead consortium of EU Member State HTA bodies carrying out joint clinical assessments (JCA) under the HTA Regulation.

The Belgian health technology assessment (HTA) body, INAMI-RIZIV, will lead the consortium of EU Member State HTA bodies that will carry out joint clinical assessments under the HTA Regulation. The consortium was formed under the guidance of the Heads of the HTA Agencies Group (HAG). HAG is an independent group of 32 European healthcare agencies working together to advance strategic collaboration on HTA. The consortium will receive a total of €35m under the EU4 Health Program, which is intended to contribute to long-term health challenges by building stronger, more resilient and more accessible health systems. Each agency receiving support from the European Commission to correctly perform the assessments.